For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
Our dedicated team of pediatric experts brings a patient- and family-centered approach to protocol development and study conduct to improve participation, accommodate patients’ needs, and successfully support your trials from start to finish. We’ll identify the best sites, maximize patient recruitment and retention, and handle all technical and logistical challenges to ensure your treatment reaches the children who need it.
Our team includes 20+ pediatricians and physicians with pediatric experience around the world, across a variety of therapeutic areas. This allows us to facilitate M.D.-to-M.D. support and discussion, no matter the therapeutic indication or location of the study. Our Chief Patient Officer, patient insight and rare disease experts also have significant experience in pediatrics, ensuring that our efforts are fueled by patient insights and that any pediatric disease, no matter how rare, is fully supported.
Our experts in Pediatrics
The decisions we make are based on a deep understanding of the nuances of the pediatric population, including ethical considerations and the many operational complexities involved, such as precision dosing, blood draws, and informed consent. We know how to address patient needs, parent concerns, and trial complexities — all to drive better results for your patients and trial.
At least 50% of rare diseases affect children. That’s why our rare disease and pediatric teams have remained closely aligned and linked to our Rare Disease Center of Excellence. With significant practical experience in rare disease trials, we apply our insights to rare pediatric projects and can tap into shared expertise in genomics and precision medicine to meet the unique needs of your trial.
Tap into our extensive pediatric medical expertise in all major regions of the world.
Access our global regulatory team, with expertise in pediatric investigation plans and pediatric study plans.
Predict drug effects and create efficiencies with advanced modeling and simulation, including PK, PD, and pediatric formulations.
Implement innovative trial approaches, including decentralized and adaptive trial designs, and incorporate real-world data.
Collaborate with a broad network of pediatric site alliances, site management organizations, and larger pediatric networks.
Improve patient identification and recruitment with site support, clinical enrollment managers, and informed consent videos.
Stay attuned to the needs of the patient and family with help from our Patient Innovation Center.